Reference Range
Argatroban: therapeutic range 0.4-1.2µg/m[1]
Dabigatran: target peak range 117-275 ng/ml for stroke prevention in NVAF and treatment of PE/VTE[1]
[1] Measurement of heparin, direct oral anti-coagulants and other non-coumarin anti-coagulants and their effects on haemostasis assays: A British Society for Haematology Guideline, Baker et al, Brit J Haematol, 2024.